DE60104697D1 - Sulfonamid-derivate - Google Patents
Sulfonamid-derivateInfo
- Publication number
- DE60104697D1 DE60104697D1 DE60104697T DE60104697T DE60104697D1 DE 60104697 D1 DE60104697 D1 DE 60104697D1 DE 60104697 T DE60104697 T DE 60104697T DE 60104697 T DE60104697 T DE 60104697T DE 60104697 D1 DE60104697 D1 DE 60104697D1
- Authority
- DE
- Germany
- Prior art keywords
- sulfonamide derivatives
- psychiatric
- useful
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21136500P | 2000-06-13 | 2000-06-13 | |
US211365P | 2000-06-13 | ||
PCT/US2001/010840 WO2001096289A1 (en) | 2000-06-13 | 2001-05-30 | Sulfonamide derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60104697D1 true DE60104697D1 (de) | 2004-09-09 |
DE60104697T2 DE60104697T2 (de) | 2005-08-04 |
Family
ID=22786629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60104697T Expired - Fee Related DE60104697T2 (de) | 2000-06-13 | 2001-05-30 | Sulfonamid-derivate |
Country Status (9)
Country | Link |
---|---|
US (1) | US6703425B2 (de) |
EP (1) | EP1296945B1 (de) |
JP (1) | JP2004503527A (de) |
AT (1) | ATE272617T1 (de) |
AU (1) | AU2001274806A1 (de) |
CA (1) | CA2411811A1 (de) |
DE (1) | DE60104697T2 (de) |
ES (1) | ES2225558T3 (de) |
WO (1) | WO2001096289A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
US6639107B1 (en) | 1999-12-08 | 2003-10-28 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
CN1902181A (zh) * | 2003-10-28 | 2007-01-24 | 沃泰克斯药物股份有限公司 | 可用作离子通道调控剂的苯并咪唑 |
BRPI0514191A (pt) * | 2004-08-09 | 2008-06-03 | Glaxo Group Ltd | compostos que potencializam o receptor glutamato e seus usos em medicina |
US8007849B2 (en) * | 2005-12-14 | 2011-08-30 | International Flavors & Fragrances Inc. | Unsaturated cyclic and acyclic carbamates exhibiting taste and flavor enhancement effect in flavor compositions |
JP2010517926A (ja) * | 2006-02-08 | 2010-05-27 | グラクソ グループ リミテッド | グルタミン酸受容体を増強する、統合失調症の治療に有用な4−フェニル−3−(2−プロピルスルホニルアミノ)テトラヒドロフラン誘導体 |
US20070293573A1 (en) * | 2006-02-24 | 2007-12-20 | Eric Gouaux | Glu2 receptor modulators |
US20090270508A1 (en) * | 2007-02-23 | 2009-10-29 | James Eric Gouaux | GluR2 receptor modulators |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
CA2915405A1 (en) | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
CN109678812B (zh) * | 2018-12-30 | 2022-09-02 | 天津大学 | 一种5-乙烯基-2-硫代恶唑烷的制备方法 |
EP4201978A4 (de) * | 2020-08-20 | 2024-02-14 | Mitsubishi Gas Chemical Co | Polyamidharz |
KR102564276B1 (ko) * | 2020-08-20 | 2023-08-07 | 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 | 폴리아미드 수지 |
KR20230165753A (ko) | 2021-04-08 | 2023-12-05 | 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 | 에폭시 수지 경화제, 에폭시 수지 조성물 및 도료 |
WO2022230656A1 (ja) | 2021-04-26 | 2022-11-03 | 三菱瓦斯化学株式会社 | 化合物及びその製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1166622C (zh) | 1995-02-01 | 2004-09-15 | 法玛西雅厄普约翰美国公司 | 作为选择性多巴胺d3配体的2-氨基-1,2-二氢化茚 |
GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
JP3817045B2 (ja) * | 1997-09-12 | 2006-08-30 | 四国化成工業株式会社 | 溶融塩型高分子電解質 |
JP2002504502A (ja) | 1998-02-24 | 2002-02-12 | イーライ・リリー・アンド・カンパニー | スルホンアミド誘導体 |
AU5235699A (en) * | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Sulfonamide derivatives |
EA200201233A1 (ru) | 2000-05-19 | 2003-04-24 | Эли Лилли Энд Компани | Способ получения бифенильных соединений |
AU2001259053A1 (en) | 2000-05-19 | 2001-12-03 | Eli Lilly And Company | Sulfonamide derivatives |
-
2001
- 2001-05-30 ES ES01941453T patent/ES2225558T3/es not_active Expired - Lifetime
- 2001-05-30 DE DE60104697T patent/DE60104697T2/de not_active Expired - Fee Related
- 2001-05-30 WO PCT/US2001/010840 patent/WO2001096289A1/en active IP Right Grant
- 2001-05-30 JP JP2002510433A patent/JP2004503527A/ja not_active Withdrawn
- 2001-05-30 AT AT01941453T patent/ATE272617T1/de not_active IP Right Cessation
- 2001-05-30 AU AU2001274806A patent/AU2001274806A1/en not_active Abandoned
- 2001-05-30 US US10/276,738 patent/US6703425B2/en not_active Expired - Fee Related
- 2001-05-30 CA CA002411811A patent/CA2411811A1/en not_active Abandoned
- 2001-05-30 EP EP01941453A patent/EP1296945B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20030229102A1 (en) | 2003-12-11 |
WO2001096289A1 (en) | 2001-12-20 |
US6703425B2 (en) | 2004-03-09 |
AU2001274806A1 (en) | 2001-12-24 |
CA2411811A1 (en) | 2001-12-20 |
DE60104697T2 (de) | 2005-08-04 |
JP2004503527A (ja) | 2004-02-05 |
EP1296945A1 (de) | 2003-04-02 |
ES2225558T3 (es) | 2005-03-16 |
EP1296945B1 (de) | 2004-08-04 |
ATE272617T1 (de) | 2004-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE272617T1 (de) | Sulfonamid-derivate | |
FI950309A0 (fi) | Proliiniamidijohdannaisia | |
AP2002002637A0 (en) | Novel piperazine | |
GC0000375A (en) | Benzodiazepine derivatives as gaba a receptor modulators | |
EA200300982A1 (ru) | Гетероциклические производные для лечения рака и других пролиферативных заболеваний | |
MXPA03011954A (es) | Nuevos derivados de acido sulfonico. | |
DE60120427D1 (de) | Radicicol und monocillin und ihre analogen und ihre anwendungen | |
ID24846A (id) | Turunan-turunan bifenilamidina | |
AP2001002306A0 (en) | Bridged piperazine derivatives. | |
EA200201232A1 (ru) | Производные сульфонамида | |
EA200201234A1 (ru) | Производные сульфонамида | |
ATE298742T1 (de) | Zykloalkenylsulfonamidderivate | |
AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
DK1049672T3 (da) | Azetidincarboxamid-derivater til behandling af CNS-lidelser | |
SI1603877T1 (sl) | Novi derivati aminopiridina kot antagonisti mGiuR5 | |
DE60211866D1 (de) | Thiophen substituierte amin derivate als glyt-1 inhibitoren | |
DK1049670T3 (da) | Azetidincarboxamidderivater til behandling af CNS-lidelser | |
EA200501053A1 (ru) | Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |